Company / Shareholders' Equity
AGIOS PHARMACEUTICALS, INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.2B
FY2025
5-year range
$399.5M / $1.5B
FY2021-FY2025
Trend
-22.6%
vs FY2024
Sector context
#40 of 213
Health Care
What the data says
AGIOS PHARMACEUTICALS, INC.'s shareholders' equity of $1.2B is higher than 81% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 10 years, ranging from $359M in FY2018 to $1.5B in FY2024.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +11.7%. Top quartile in the Health Care sector.
Improved from $811M to $1.2B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +44.0%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Sector benchmark
-53.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.7%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 22.6% year-over-year.
- Ranks #40 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | -22.6% |
| FY2024 | $1.5B | +90.0% |
| FY2023 | $811.0M | +103.0% |
| FY2022 | $399.5M | -69.1% |
| FY2021 | $1.3B | +87.9% |
| FY2020 | $687.5M | +7.3% |
| FY2019 | $640.5M | +78.6% |
| FY2018 | $358.6M | -4.5% |
| FY2017 | $375.5M | +4.7% |
| FY2016 | $358.6M | +172.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026